FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321639652> ?p ?o ?g. }

• W4321639652 endingPage "ii41" @default.
• W4321639652 startingPage "ii9" @default.
• W4321639652 abstract "Abstract Background Prescribing in older persons is complex and involves greater risk of drug-related harm. Prescribing appropriate anticoagulation balancing thromboembolic versus bleeding risk is essential with consideration to multiple comorbidities and polypharmacy. 27% of adults were prescribed inappropriate anticoagulation dosing in the GARFIELD-AF study. The Health Service Executive provides guidelines under the medicines management programme on prescribing anticoagulation treatment. The European Heart Rhythm Association (EHRA) published an updated practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in 2021. Methods A point prevalence audit was carried out in a community hospital rehabilitation unit, including all inpatients receiving oral anticoagulants (OAC). The data collected included: age, OAC prescribed, dose, documentation of indication, length of treatment, if a reduced dose was prescribed and reason why, creatinine clearance and reason for co-prescribing of an antiplatelet agent. Results were collected, analysed, and compared with the above guidelines. Results 25 inpatients were included. 9 were on an OAC (36%). All patients were 70 years or over. DOACs were prescribed in 7 patients and warfarin in 2. All patients had a prescribing indication documented. All patients had an appropriate treatment duration documented. 3 OAC users were on a reduced dose, all of whom had an indication for a reduced dose documented. 1 patient was on medications with a documented drug–drug interaction. Only 3 patients had their creatinine clearance documented. No inpatients were co-prescribed an antiplatelet agent. Conclusion Creatinine clearance is an important factor in prescribing of OAC and must be documented. Interventions to improve documentation of creatinine clearance will be explored and implemented. Consideration to drug–drug interactions in older patients with polypharmacy requires a multidisciplinary approach including pharmacy input." @default.
• W4321639652 created "2023-02-24" @default.
• W4321639652 creator A5011003738 @default.
• W4321639652 creator A5012261459 @default.
• W4321639652 creator A5031908378 @default.
• W4321639652 creator A5037714575 @default.
• W4321639652 creator A5053589861 @default.
• W4321639652 creator A5055196392 @default.
• W4321639652 creator A5065589449 @default.
• W4321639652 creator A5082149970 @default.
• W4321639652 creator A5083497250 @default.
• W4321639652 creator A5086785814 @default.
• W4321639652 creator A5088233772 @default.
• W4321639652 creator A5088919762 @default.
• W4321639652 date "2021-11-01" @default.
• W4321639652 modified "2023-09-28" @default.
• W4321639652 title "244 ORAL ANTICOAGULANT PRESCRIBING IN OLDER PERSONS: AN AUDIT OF A COMMUNITY HOSPITAL REHABILITATION UNIT" @default.
• W4321639652 doi "https://doi.org/10.1093/ageing/afab219.244" @default.
• W4321639652 hasPublicationYear "2021" @default.
• W4321639652 type Work @default.
• W4321639652 citedByCount "0" @default.
• W4321639652 crossrefType "journal-article" @default.
• W4321639652 hasAuthorship W4321639652A5011003738 @default.
• W4321639652 hasAuthorship W4321639652A5012261459 @default.
• W4321639652 hasAuthorship W4321639652A5031908378 @default.
• W4321639652 hasAuthorship W4321639652A5037714575 @default.
• W4321639652 hasAuthorship W4321639652A5053589861 @default.
• W4321639652 hasAuthorship W4321639652A5055196392 @default.
• W4321639652 hasAuthorship W4321639652A5065589449 @default.
• W4321639652 hasAuthorship W4321639652A5082149970 @default.
• W4321639652 hasAuthorship W4321639652A5083497250 @default.
• W4321639652 hasAuthorship W4321639652A5086785814 @default.
• W4321639652 hasAuthorship W4321639652A5088233772 @default.
• W4321639652 hasAuthorship W4321639652A5088919762 @default.
• W4321639652 hasBestOaLocation W43216396521 @default.
• W4321639652 hasConcept C126322002 @default.
• W4321639652 hasConcept C177713679 @default.
• W4321639652 hasConcept C194828623 @default.
• W4321639652 hasConcept C2776301958 @default.
• W4321639652 hasConcept C2777288759 @default.
• W4321639652 hasConcept C2779161974 @default.
• W4321639652 hasConcept C36434225 @default.
• W4321639652 hasConcept C71924100 @default.
• W4321639652 hasConceptScore W4321639652C126322002 @default.
• W4321639652 hasConceptScore W4321639652C177713679 @default.
• W4321639652 hasConceptScore W4321639652C194828623 @default.
• W4321639652 hasConceptScore W4321639652C2776301958 @default.
• W4321639652 hasConceptScore W4321639652C2777288759 @default.
• W4321639652 hasConceptScore W4321639652C2779161974 @default.
• W4321639652 hasConceptScore W4321639652C36434225 @default.
• W4321639652 hasConceptScore W4321639652C71924100 @default.
• W4321639652 hasIssue "Supplement_3" @default.
• W4321639652 hasLocation W43216396521 @default.
• W4321639652 hasOpenAccess W4321639652 @default.
• W4321639652 hasPrimaryLocation W43216396521 @default.
• W4321639652 hasRelatedWork W1473422855 @default.
• W4321639652 hasRelatedWork W1490431006 @default.
• W4321639652 hasRelatedWork W2007116565 @default.
• W4321639652 hasRelatedWork W2010333783 @default.
• W4321639652 hasRelatedWork W2050979405 @default.
• W4321639652 hasRelatedWork W2339152339 @default.
• W4321639652 hasRelatedWork W2404340513 @default.
• W4321639652 hasRelatedWork W2489662481 @default.
• W4321639652 hasRelatedWork W2569205071 @default.
• W4321639652 hasRelatedWork W3158539620 @default.
• W4321639652 hasVolume "50" @default.
• W4321639652 isParatext "false" @default.
• W4321639652 isRetracted "false" @default.
• W4321639652 workType "article" @default.